CHEMICAL CONSULTANTS NETWORK

Drug Design lectures at PA Biotech Center

13 Dec 2018 11:49 AM | Dr. Keith D. Wing (Administrator)

From: Debbie Blough <debbie.blough@bblumberg.org>
Date: Wed, Dec 12, 2018 at 2:29 PM
Subject: FW: Announcing Drug Design Lecture Series with Nicholas Meanwell
To: debbie.blough@bblumberg.org. <debbie.blough@bblumberg.org>

Good Afternoon:

Announcing a new lecture series titled Topics in Drug Designhosted by Nicholas A. Meanwell, Ph.D.  Beginning January 8 and running through 2019, Dr. Meanwell will deliver 6 lectures on drug design.  Lectures are from 4 – 5 PM, and will be in Room 100 at the PA Biotechnology Center, 3805 Old Easton Road, Doylestown, PA 18902. Please join us – and feel free to forward this announcement to your colleagues!

Dr. Meanwell has a Ph.D. from the University of Sheffield and completed a Postdoctoral Fellowship at Wayne State University. He joined Bristol-Myers Squibb in 1982 and has led the antiviral chemistry group since 1992. They have pioneered several mechanistically novel antiviral approaches including influenza and respiratory syncytial virus fusion inhibitors, HIV-1 attachment inhibitors and HCV NS5A inhibitors. They have also completed Phase 3 clinical trials of a combination of the HCV NS5A inhibitor daclatasvir and the HCV NS3 inhibitor asunaprevir.


The ideas, advice and positions expressed by individual members of the Chemical Consultants Network are the member's own and not the responsibility of CCN or its sponsors, the American Chemical Society and the American Institute of Chemical Engineers.

© 2017 Chemical Consultants Network 

Chemical Consultants Nework is jointly supported by AlChE and ACS

Powered by Wild Apricot Membership Software